Actively Recruiting
ASTHMAXcel Voice Study
Led by Montefiore Medical Center · Updated on 2025-10-24
200
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
Sponsors
M
Montefiore Medical Center
Lead Sponsor
Y
Yeshiva University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
CONDITIONS
Official Title
ASTHMAXcel Voice Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English speaking
- Diagnosed with persistent asthma by a healthcare provider
- Currently using a daily controller medication for asthma
- Able to provide informed consent
- Have access to a smartphone (iOS or Android) with a data plan
You will not qualify if you...
- Pregnant
- Severe psychiatric or cognitive problems that would prevent completing the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Montefiore Medical Center
The Bronx, New York, United States, 10467
Actively Recruiting
Research Team
S
Sunit Jariwala, MD
CONTACT
J
Juliana D Rodriguez, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here